Mankind Pharma Ltd
BSE:543904
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mankind Pharma Ltd
BSE:543904
|
IN |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
XBER:MCH
|
FR |
|
T
|
Teradyne Inc
XBER:TEY
|
US |
|
D
|
Diageo PLC
OTC:DGEAF
|
UK |
|
Equinor ASA
OSE:EQNR
|
NO |
|
Shimano Inc
TSE:7309
|
JP |
|
Siemens Energy AG
OTC:SMEGF
|
DE |
Wall St Price Targets
MANKIND Price Targets Summary
Mankind Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 574.1367 INR with a low forecast of 2 013.6208 INR and a high forecast of 3 261.026 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MANKIND's stock price target?
Price Target
2 574.1367
INR
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 574.1367 INR with a low forecast of 2 013.6208 INR and a high forecast of 3 261.026 INR.
What is the Revenue forecast for Mankind Pharma Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 14%.
What is the Operating Income forecast for Mankind Pharma Ltd?
Projected CAGR
17%
Over the last 4 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Mankind Pharma Ltd?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 15%.
